Budesonide
53 NDCs across 28 manufacturers|45 Generic,8 Brand
Budesonide is used to treat inflammatory bowel diseases and rhinitis, allergic, perennial, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Feb 14, 1994, and the first generic was approved Nov 18, 2008. FDA's Orange Book lists 11 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $197 million on Budesonide across 641,000 claims for 215,000 beneficiaries.
Budesonide is available as 53 NDCs from 28 manufacturers (45 generic, 8 brand), with NADAC prices from $0.68 to $9.84 per ML — the most expensive product costs about 15× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
53
45G / 8B
Manufacturers
28
competing in market
Price Spread
$0.68 – $9.84
per ML, 37 of 53 NDCs
7d Activity
avg -3.1% WoW · of 53 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Cipla USA Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Corticosteroid class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
28 manufacturers producing BUDESONIDE(2 pricing outliers)
Frequently Asked Questions
What is Budesonide used to treat?
Budesonide is used to treat inflammatory bowel diseases and rhinitis, allergic, perennial, per the National Library of Medicine's MED-RT classification.
When did Budesonide become available as a generic?
FDA approved the first generic Budesonide (ANDA) on Nov 18, 2008. The Orange Book currently lists 11 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Budesonide?
In 2024, Medicare Part D spent $197 million on Budesonide across 641,000 claims for 215,000 beneficiaries.
How many Budesonide products are on the market?
The Budesonide drug market contains 53 NDCs from 28 manufacturers — 45 generic and 8 brand products.
What is the price range for Budesonide?
NADAC reference prices for Budesonide range from $0.6761 to $9.8448 per ML — the most expensive product costs about 15× the cheapest. 16 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Is generic Budesonide cheaper than brand?
The average generic NADAC for Budesonide is $1.2833 per ML, versus $5.5602 for brand-labeled products — brand versions average about 4.3× the generic price.
Which manufacturers make Budesonide?
28 manufacturers list Budesonide in NADAC. Ranked by number of NDCs, the largest are Cipla USA Inc. (6), Teva Pharmaceuticals USA Inc. (5), Nephron Pharmaceuticals Corporation (4), AstraZeneca Pharmaceuticals LP (3), Exelan Pharmaceuticals Inc. (3).
How has the price of Budesonide changed recently?
Over the past 7 days, 3 Budesonide NDCs rose and 35 fell, with a market-wide average change of -3.1%.